亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Fresh Frozen Plasma for the Treatment of Hereditary Angioedema Acute Attacks

        2012-11-18 13:33:36RuiTangShiChenandHongyuZhang
        Chinese Medical Sciences Journal 2012年2期

        Rui Tang,Shi Chen,and Hong-yu Zhang*

        1Department of Allergy,2Department of Endocrinology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College,Beijing 100730,China

        HEREDITARY angioedema (HAE) is a rare autosomal dominant disease with an estimated prevalence of 1∶50 000,characterized by episodic edema of the skin,subcutaneous tissues or mucous membranes.Life may be threatened when laryngeal edema appeared.The disease is due to deficiency of the quantity and/or function of C1 inhibitor (C1INH).HAE can be usually divided into two types.HAE type I is up to 85% of all patients,and there is a deficiency in the amount of C1INH protein.In HAE type II,the circulating C1INH concentration is normal or high,but C1INH not fully functional.1

        Treatment for HAE includes prophylaxis and aute attacks.C1INH concentrates,2nanofiltered C1INH,3recombinant C1INH,4kallikrein inhibitor ecanllantide5,and bradykinin B2 receptor antagonist icatibant6are the options for acute attacks of HAE.But at present the abovementioned therapies are unavailable in China and there is also no experience on treatment for acute attacks of HAE.Fresh frozen plasma (FFP) is often used as a source of C1INH to treat acute attacks in the United States.7We first reported a Chinese HAE patient successfully treated with FFP for acute attack in 2009.8In this study,we retrospectively analyzed 2 patients undergoing treatment for HAE at Peking Union Medical College Hospital and 11 patients reported in the medical literatures who received FFP infusion,to determine if there was evidence that FFP infusion was safe and effective for acute attacks of HAE patients.

        PATIENTS AND METHODS

        Data collection

        We retrospectively searched the medical records in Peking Union Medical College Hospital during 2004 and 2010 to identify the patients diagnosed with HAE receiving FFP infusion.All patients were diagnosed according to 2010 international HAE consensus.9Patient having angioedema caused by allergen or medicine was excluded.Meanwhile,we searched PubMed database from 1966 to the present using the following key words∶hereditary angioedema and fresh frozen plasma.We identified relevant articles written in English.

        Data analysis

        The following information was recorded∶patient’s age,sex,body location of HAE attacks,the dose of FFP infusion,time of beginning to improvement,time to complete remission,complication,C1INH activity,and outcome,to determine the safety and efficacy of FFP infusion for acute attacks of HAE patients.

        C1INH activity in FFP was 60 000.Normal range of C1INH activity was 60 000-100 000.10

        Statistical analysis

        Statistical analysis was performed with SPSS software version 11.0 for Windows.The normally distributed data were presented as mean±SD.Significant differences between the groups were evaluated using Student’st-test.The abnomally distributed data were accessed by median(P25,P75).Significant differences between the groups were compared usingFisher’sexact test.A value ofP<0.05 was considered statistically significant.

        RESULTS

        General information

        A total of 13 patients (7 male and 6 female) experiencing 16 acute attacks were enrolled.The mean age was 30±17 years old.The mean age of male and female patients was 27±15 and 28±18 years,respectively.There was no significant difference between male and female in the mean age (t=-0.061,P=0.952).One type-Ⅰ and one type-Ⅱ HAE patients were diagnosed in Peking Union Medical College Hospital.Other 11 HAE patients reported in the literature included 4 type-Ⅰand 7 unknown type.10-17The 13 HAE patients received 16 times of FFP infusion(Table 1).

        Clinical manifestation

        Acute attacks manifested as laryngeal edema for 5 cases,abdominal pain for 5 cases,and facial edema for 3 cases(Table 1).

        The mean age of 5 cases experiencing laryngeal edema was 20±5 years old,and that of other 8 cases without laryngeal edema was 35±20 years old (Table 1).So there was a trend the patients suffering from laryngeal edema were younger,although difference was not statistically significant (t=-2.086,P=0.056).

        Infusion dose of FFP

        The mean dose of FFP infusion was 586±337 mL (Table 1).There was no significant difference between male and female in the dose of FFP infusion (581±259vs.519±451 mL,t=1.322,P=0.209).The FFP dosage was lower in the laryngeal edema group (375±128vs.657±256 mL,t=-2.760,P=0.016).

        Adverse events

        Symptoms of all cases were improved except 1 because of transfusion reaction.The only adverse event recorded was rash,fever and chilling occurred in 1 case,which were considered to be allergic reaction to FFP infusion.Abdominal pain of 2 cases was exacerbated in the first few minutes of FFP infusion,but the symptom completely disappeared within 1.5 to 2.5 hours of FFP treatment(Table 1).10,13

        C1INH activity

        There were two records of change of C1INH activity in the literature.10After 400 mL of FFP infusion,C1INH activities in both patients after plasma infusion increased from 10 000 to 26 500 and from 16 000 to 25 000,respectively.

        Outcome

        The mean time of beginning to improvement was 49±19 minutes for 8 acute HAE attacks (Table 1).

        Table 1.Clinical characteristics of patients with HAE undergoing FFP infusion for acute attacks

        A total of 7 acute attacks (5 cases) had definite records of remission time without FFP treatment,which was 61.7±27.0 hours.The median of remission time of 10 acute attacks shortened to 3.3 (2.0,12.0) hours after FFP infusion (P<0.01,Table 1).

        DISCUSSION

        HAE is a rare autosomal dominant disease,characterized by edema of the skin,subcutaneous tissues or the mucous membranes of the gastrointestinal and upper respiratory tracts.Laryngeal edema occurred in 48%-78%of HAE patients,and the risk for asphyxialdeath was 30%-50%.18The manifestation is similar to the angioedema caused by allergen or medicine,so in the emergency room antihistamines,glucocorticoid or epinephrine is usually administrated to control angioedema,but the upper-mentioned medicines have no effect for angioedema attacks of HAE.

        HAE is caused by deficiency in C1INH.C1INH is not only the main regulator of the early steps of the classic complement pathway,but also important inhibitor of kallikrein.C1INH deficiency will activate the classic complement pathway and bradykinin,leading to edema.At present,replacement therapy with C1INH is recommended to treat an acute attack of HAE,but which is unavailable in China.

        FFP is separated from the whole blood within 6-8 hours after collection,which can be conserved for 1 year under-18°C.FFP contains all coagulation factors except for platelet,so FFP can be used for treatment of acute attacks of HAE.19We reported FFP infusion as the treatment for acute attacks of HAE in China in 2009.8But it is hypothesized FFP might worsen an acute attack of HAE for it contains potentially harmful substrates.20

        Angioedema attacks various organs.In this report,the manifestation of FFP treated cases ranged from abdominal pain to facial angioedema to life-threatening laryngeal edema.The patients with laryngeal edema were younger than those with abdominal pain or facial edema,so the clinical doctor should pay attention to the laryngeal edema among the younger patients.In this cohort,375±128 mL of FFP seemed to be able to achieve an improvement in symptoms of patients with laryngeal edema,meanwhile 657±256 mL of FFP seemed effective for the other cases.So 400-600 mL of FFP seemed enough for acute attacks of HAE.

        Improvement in symptom appeared in all cases except one because of transfusion reaction.FFP was an efficacious remedy for every type of exacerbation.And 2 cases reported in the literature suffered from worsening abdominal pain within the first few minutes of FFP infusion for an acute attack,but achieved complete resolutions within 1.5 to 2.5 hours of treatment.10,13We can not identify if the abdominal symptom are due to FFP infusion.

        After 49±19 minutes of beginning the infusion,there was a definite improvement.At 3.3 hours of infusion,HAE patients were completely free of laryngeal edema,abdominal pain or facial edema.The remission time was obviously shorter than that of patients without FFP transfusion (61.7±27.0 hours).There was an increase in C1INH activity after the infusion,which indicated that the plasma infusion provided the patients with C1INH,leading to the release of acute attacks.

        FFP can induce allergic reaction or virus infection as blood products.The only adverse event recorded was rash,fever and chilling,which were considered to be allergic reaction to FFP,and were easily alleviated with antihistamines.So plasma derived C1INH and recombinant C1INH is required in China to treat acute HAE attacks.

        In conclusion,FFP seems to be safe and effective when used for treatment of acute HAE attacks.

        1.Cicardi M,Bork K,Caballero T,et al.Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency∶consensus report of an International Working Group.Allergy 2012;67∶147-57.

        2.Craig TJ,Bewtra AK,Bahna SL,et al.C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks—final results of the I.M.P.A.C.T.2 study.Allergy 2011;66∶1604-11.

        3.Zuraw BL,Busse PJ,White M,et al.Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.N Engl J Med 2010;363∶513-22.

        4.Zuraw B,Cicardi M,Levy RJ,et al.Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.J Allergy Clin Immunol 2010;126∶821-7.

        5.Cicardi M,Levy RJ,McNeil DL,et al.Ecallantide for the treatment of acute attacks in hereditary angioedema.N Engl J Med 2010;363∶523-31.

        6.Cicardi M,Banerji A,Bracho F,et al.Icatibant,a new bradykinin-receptor antagonist,in hereditary angioedema.N Engl J Med 2010;363∶532-41.

        7.Prematta M,Gibbs JG,Pratt EL,et al.Fresh frozen plasma for the treatment of hereditary angioedema.Ann Allergy Asthma Immunol 2007;98∶383-8.

        8.Tang R,Zhang HY,Gan J.Fresh frozen plasma for the treatment of a Chinese patient with hereditary angioedema.Chin Med Sci J 2009;24∶246-7.

        9.Bowen T,Cicardi M,Farkas H,et al.2010 International consensus algorithm for the diagnosis,therapy and management of hereditary angioedema.Allergy Asthma Clin Immunol 2010;6∶24.

        10.Pickering RJ,Good RA,Kelly JR,et al.Replacement therapy in hereditary angioedema∶successful treatment of two patients with fresh frozen plasma.Lancet 1969;1∶326-30.

        11.Hamilton AG,Bosley ARJ,Bowen DJ.Laryngeal oedema due to hereditary angioedema.Anaesthesia 1977;32∶265-7.

        12.Cohen G,Peterson A.Treatment of hereditary angioedema with fresh frozen plasma.Ann Allergy 1972;30∶690-2.

        13.Beck P,Wills D,Lachmann PJ,et al.A family study of hereditary angioneurotic oedema.QJM 1973;42∶317-39.

        14.Ohela K,Rasanen JA,Wager O.Hereditary angio-neurotic oedema∶genealogical and immunological studies.Ann Clin Res 1973;5∶174-80.

        15.Wall RT,Frank M,Hahn M.A review of 25 patients with hereditary angioedema requiring surgery.Anesthesiology 1989;71∶309-11.

        16.Cohen N,Sharon A,Golik A,et al.Hereditary angioneurotic edema with severe hypovolemic shock.J Clin Gastroenterol 1993;16∶237-9.

        17.McGlinchey PG,Golchin K,McCluskey DR.Life-threatening laryngeal oedema in a pregnant woman with hereditary angioedema.Ulster Med J 2000;69∶54-7.

        18.Farkas H.Management of upper airway edema caused by hereditaryangioedema.Allergy Asthma Clin Immunol 2010;6∶19.

        19.Bowen T,Cicardi M,Bork K,Hereditary angiodema∶a current state-of-the-art review,VII∶Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis,Therapy,and Management of Hereditary Angioedema.Ann Allergy Asthma Immunol 2008;100∶S30-40.

        20.Donaldson VH.Therapy of the neurotic edema.N Engl J Med 1972;286∶835.

        婷婷久久亚洲中文字幕| 久久精品国产亚洲av麻豆| 麻豆国产原创视频在线播放| 欧美情侣性视频| 国产午夜亚洲精品不卡免下载| 久久久精品人妻一区二区三区免费| 国产一区二区三区av免费| 亚洲精品无码永久在线观看| 少妇无码太爽了不卡视频在线看| 含羞草亚洲AV无码久久精品| 国产传媒剧情久久久av| 日本高清一区二区不卡| 日日噜噜夜夜狠狠久久丁香五月| 国产精品r级最新在线观看| 欧美精品偷自拍另类在线观看| 亚洲αv在线精品糸列| 国产一区二区三区18p| 国产精品亚洲av无人区一区香蕉| 性xxxx18免费观看视频| 97一区二区国产好的精华液| 丰满少妇人妻无码超清| 亚洲白嫩少妇在线喷水| av区无码字幕中文色| 无码午夜成人1000部免费视频| 久久人人做人人妻人人玩精| 亚洲精品一区二区视频| 日本一本一道久久香蕉男人的天堂| 又大又长粗又爽又黄少妇视频| 久久国产热这里只有精品| 中文岛国精品亚洲一区| 精品自拍偷拍一区二区三区| 亚洲天堂二区三区三州| 欧美性色黄大片手机版| 亚洲AV秘 无码一区二区三区臀| 国产成人福利av一区二区三区| 开心激情视频亚洲老熟女| 亚洲av无码久久| 香蕉视频www.5.在线观看| 久青青草视频手机在线免费观看| 久久久亚洲免费视频网| 国产三级精品三级|